ZimVie Inc., a global life sciences leader in the dental and spine markets, has announced the joint launch of the new, FDA-cleared T3 PRO Tapered Implant and Encode Emergence Healing Abutment in the United States.
The T3 PRO is the newest addition to ZimVie’s family of dental implants and builds on the proven solutions of the T3 Tapered Implant. The Encode Emergence Healing Abutment builds upon ZimVie’s 3-in-1 Encode Impression System which provides clear intraoral scans and aesthetics, and is designed for patient comfort and healing.
Both the T3 PRO and the Encode Emergence reflect significant innovation to ZimVie’s previous products and promise an optimised implant experience for both dentists and patients. ZimVie will begin commercial rollout of these solutions in the United States, with an intention to expand to additional countries pending necessary regulatory approvals.
“We are excited to launch the next evolution in our T3 family of implants and Encode impression system, which has been used in more than two million implant restoration procedures to date,” said Indraneel Kanaglekar, SVP and president of ZimVie Dental. “ZimVie is committed to providing innovative treatment options to improve patient care while partnering with dental professionals globally to advance dental technology and end-to-end workflow solutions.”